英語論文

1 Ando K, Okhuni Y, Matsunuma R, Nakashima K, Iwasaki T, Asai N, Yasui D,
Misawa M, Kaneko N. Prognostic lung abscess factors. Kansenshogaku Zasshi. 2010
Jul;84(4):425-30.

2 Ando K, Ohkuni Y, Misawa M, Yasui D, Asai N, Iwasaki T, Nakashima K,
Matsunuma R, Kaneko N, Narita M. Cryptococcemia with a severe bronchial asthma: case report and review of the literature.
Arerugi. 2009 Nov;58(11):1536-43.

3 Ando K, Ohkuni Y, Makino H, Komatsu A, Matsunuma R, Nakashima K, Asai N,
Kaneko N. A clinical review of pleurodesis for patients with poor performance status.
Nihon Kokyuki Gakkai Zasshi. 2011 Oct;49(10):723-8.

4 Asai N, Ohkuni Y, Komatsu A, Matsunuma R, Nakashima K, Kaneko N. Severe
persistent asthma responsive to off-label use of omalizumab despite high and low
levels of total serum IgE. J Bras Pneumol. 2011 Jul-Aug;37(4):567-70.

5 Nakashima K, Asai N, Ohkuni Y, Matsunuma R, Iwasaki T, Kaneko N. Two cases of type I respiratory failure managed by the highFO nebulizer. Nihon Kokyuki GakkaiZasshi. 2011 Jul;49(7):511-6.

6 Asai N, Ohkuni Y, Matsunuma R, Nakashima K, Iwasaki T, Kaneko N. Infectiousgiant bulla associated with lung cancer. J Bras Pneumol. 2011 Jun;37(3):404-8.

7 Asai N, Ohkuni Y, Iwasaki T, Matsunuma R, Nakashima K, Otsuka Y, Kaneko N.
Efficacy and safety of single-dose 2.0 g azithromycin in the treatment of acute exacerbation of chronic obstructive pulmonary disease. J Infect Chemother. 2011

8 Ando K, Ohkuni Y, Komatsu A, Matsunuma R, Nakashima K, Asai N, Makino H,
Kaneko N. The efficacy of shortening an administration period with omalizumab.
Arerugi. 2011 May;60(5):604-9.

9 Asai N, Ohkuni Y, Komatsu A, Matsunuma R, Nakashima K, Ando K, Iwasaki T,
Yasui D, Misawa M, Otsuka Y, Kaneko N. A case of asthma-complicated influenzamyocarditis. J Infect Chemother. 2011 Jun;17(3):429-32.

10 Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K, Takahashi K.
Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia. J Clin Oncol. 2013 Feb 20;31(6):e69-72.

11 Kei Nakashima, Masafumi Misawa, Makoto Narita, Haruki Kobayashi, Ryo Matsunuma, Nobuhiro Asai, Naoko Katsurada, Hideki Makino, Yoshihiro Ohkuni, Norihiro Kaneko, Masahiro Aoshima. A case of small-cell lung cancer with recurrence of solitary pancreatic metastasis detected by FDG-PET/CT. Int Canc Conf J 2012:2;107-110

12 Asai N, Ohkuni Y, Matsunuma R, Nakashima K, Iwama K, Narita M, Kaneko N.
Advanced non-small cell lung cancer associated with hemophagocytic syndrome in a
cachectic patient. Rev Bras Hematol Hemoter. 2012;34(1):64-5.

13 Asai N, Ohkuni Y, Matsunuma R, Nakashima K, Iwasaki T, Kaneko N.
Efficacy and safety of amurubicin for the elderly patients with refractory relapsed small cell
lung cancer as third-line chemotherapy. J Cancer Res Ther. 2012 Apr-Jun;8(2):266-71.

14 Asai N, Motojima S, Ohkuni Y, Matsunuma R, Nakashima K, Iwasaki T, Nakashita
T, Otsuka Y, Kaneko N. Early diagnosis and treatment are crucial for the survival
of Pneumocystis pneumonia patients without human immunodeficiency virus
infection. J Infect Chemother. 2012 Jun 13.

15 Asai N, Aoshima M, Ohkuni Y, Kobayashi H, Matsunuma R, Nakashima K, Katsurada N, Nakano H, Otsuka Y, Kawamura Y, Matsui K, Kaneko N.
A successful diagnostic case of Pneumocystis pneumonia by the loop-mediated isothermal amplification method in a patient with dermatomyositis. J Infect Chemother. 2012 Dec;18(6):898-905.

16 Kei Nakashima, Masahiro Aoshima, Yoshihiro Ohkuni, Eri Hoshino, Kohei Hashimoto, Yoshihito Otsuka. Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates. J Infect Chemother. 2014 Dec;20(12):757-61.

17 Kei Nakashima, Masahiro Aoshima, Fumi Suzuki, Junko Watanabe, Yoshihito Otsuka.
Cytomegalovirus Colitis in a Critically Ill Patient Following Severe Legionella Pneumonia with Multiple Organ Failure. Intern Med. 2016;55(5):527-31.

18 Satoshi Yamawaki, Kei Nakashima, Fumi Suzuki, Ayumu Otsuki, Junko Watanabe, Motohisa Takai, Masahiro Katsurada, Naoko Katsurada, Yoshihiro Ohkuni, Masafumi Misawa, Norihiro Kaneko, Yoshihito Otsuka, Masahiro Aoshima: Rice-Field Drowning-Associated Pneumonia in which Pseudomonas spp., Aspergillus fumigatus, and Cunninghamella sp. Are Isolated. Internal Medicine 2016;55:825-29.

19 Kei Nakashima. Masahiro Aoshima, Satoko Ohfuji, Kanzo Suzuki, Masahiro Katsurada, Naoko Katsurada, Masafumi Misawa, Yoshihito Otsuka, Kyoko Kondo, and Yoshio Hirota. Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy.Human Vaccines & Immunotherapeutics. Hum Vaccin Immunother. 2017;13:542-550

20 The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study. Naoko Katsurada, Motoi Suzuki, Masahiro Aoshima,Makito Yaegashi,Tomoko Ishifuji, Norichika Asoh,Naohisa Hamashige, Masahiko Abe, Koya Ariyoshi,Konosuke Morimoto, and on behalf of the Adult Pneumonia Study Group-Japan. BMC Infect Dis. 2017; 17: 755. (Kei Nakashima was acknowledged as one of the researchers in APSG-J.)

21 Kei Nakashima, Masahiro Aoshima, Tamao Nakashita, Masahiko Hara, Ayumu Otsuki, Satoshi Noma, Masafumi Misawa, Yoshihito Otsuka and Shinji Motojima. Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study. 2017 Jul 23. pii: S1684-1182(17)30147-0.

22 Tomoko Ishifuji, Eiichiro Sando, Norihiro Kaneko, Motoi Suzuki, Paul E. Kilgore, Koya Ariyoshi, Konosuke Morimoto, Naoto Hosokawa, Makito Yaegashi, Masahiro Aoshima, and on behalf of the Adult Pneumonia Study Group - Japan (APSG-J). Recurrent pneumonia among Japanese adults: disease burden and risk factors.BMC Pulm Med. 2017 Jan 11;17(1):12 (Kei Nakashima was acknowledged as one of the　researchers in APSG-J.)

23 Kentaro Imai, Tanaz Petigara, Melvin A. Kohn, Kei Nakashima, Masahiro Aoshima, Akihito Shito, Shinichi Kanazu. Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases. BMJ open. 2018 Mar 2;8(3):e018553.

24 Kei Nakashima, Masahiro Aoshima, Satoko Ohfuji, Satoshi Yamawaki, Masahiro Nemoto1, Shinya Hasegawa, Satoshi Noma, Masafumi Misawa, Naoto Hosokawa, Makito Yaegashi, Yoshihito Otsuka. Immunogenicity of Simultaneous Versus Sequential Administration of a 23-valent Pneumococcal Polysaccharide Vaccine and a Quadrivalent Influenza Vaccine in Older Individuals: A Randomized, Open-Label, Non-Inferiority Trial. Hum Vaccin Immunother. 2018;14(8):1923-1930.

25 Hamaguchi Sugihiro, Suzuki Motoi, Sasaki Kota, Abe M, Wakabayashi T, Sando E, Yaegashi M, Morimoto S, Asoh N, Hamashige N, Aoshima M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group – Japan. Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study.
BMC Pulm Med. 2018 May 23;18(1):88 (Kei Nakashima was acknowledged as one of the researchers in APSG-J.)

26 Akihiro Shiroshita, Kei Nakashima, Yu Tanaka, Akiko Tateishi, Masahiro Nemoto, Masahiro Aoshima. J Thromb Thrombolysis. 2018 Aug;46(2):271-273

27 Masahiro Nemoto, Satoshi Noma, Ayumu Otsuki, Kei Nakashima, Koichi Honma, Takeshi Johkoh, Junya Fukuoka, Masahiro Aoshima. Combined pulmonary fibrosis and emphysema with myeloperoxidase-antineutrophil cytoplasmic antibody positivity that resolved upon smoking cessation. Respiratory Medicine Case Reports 2018 Aug 27;25:165-169.

28 Yurika Iwasawa, Naoto Hosokawa, Mariko Harada, Satoshi Hayano, Akihiko Shimizu, Daisuke Suzuki, Kei Nakashima, Makito Yaegashi. Severe Community-acquired Pneumonia Caused by Acinetobacter baumannii Successfully Treated with the Initial Administration of Meropenem Based on the Sputum Gram Staining Findings. Internal medicine 2019 Jan 15;58(2):301-305.

29 Akihiro Shiroshita, Kei Nakashima, Masahiro Aoshima. Respir Med Case Rep. 2018 Oct 26;25:330-332.

30 Ryo Morishima, Kei Nakashima, Shinya Suzuki, Npbuo Yamami, Masahiro Aoshima. A diver with immersion pulmonary oedema and prolonged respiratory symptoms. Internal medicine 2018 Dec 24;48(4):259-261.

31 Akihiro Shiroshita, Kei Nakashima, Shinji Motojima, Masahiro Aoshima. Refractory Diffuse Alveolar Hemorrhage Caused by Eosinophilic Granulomatosis With Polyangiitis in the Absence of Elevated Biomarkers Treated Successfully by Rituximab and Mepolizumab: A Case Report. Respir Med Case Rep. 2018 Dec 15;26:112-114.

32 Akiko Tateishi, Kei Nakashima, Kazuei Hoshi, Yu Oyama, Toshiki Ebisudani, Masafumi Misawa, Masahiro Aoshima. Pulmonary Tumor Thrombotic Microangiopathy Mimicking Inhalation Lung Injury. Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.1796-18.

33 Kanzo Suzuki, Kyoko Kondo, Masakazu Washio, Kei Nakashimam, Sakae Kan, Seiichiro Imai, Kunihiko Yoshimura, Chiharu Ota, Satoko Ohfuji, Wakaba Fukushima Yoshio Hirota. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study. Hum Vaccin Immunother 2019 Feb 20:1-7. doi: 10.1080/21645515.2019.1584023

34 Akihiro Shiroshita, Yu Tanaka, Kei Nakashima, Yuki Furukawa, Yuki Kataoka. Diagnostic Accuracy of Specific IgG Antibodies for Bird Fancier's Lung: A Systematic Review and Meta-Analysis 2019 Nov;7(22):655.doi: 10.21037/atm.2019.10.65.

35 Nemoto M, Nakashima K, Noma S, Matsue Y, Yoshida K, Matsui H, Shiraishi A, Ishifuji T, Morimoto K, Ariyoshi K, Aoshima M. Prognostic value of chest computed tomography in community-acquired pneumonia patients. ERJ Open Res. 2020 Nov 23;6(4):00079-2020. doi: 10.1183/23120541.00079-2020.

36 Kondo K, Suzuki K, Washio M, Ohfuji S, Adachi S, Kan S, Imai S, Yoshimura K, Miyashita N, Fujisawa N, Maeda A, Fukushima W, Hirota Y; Pneumonia in Elderly People Study Group. Association between coffee and green tea intake and pneumonia among the Japanese elderly: a case-control study. Sci Rep. 2021 Mar 10;11(1):5570. doi: 10.1038/s41598-021-84348-w. 　(Kei Nakashima was acknowledged as one of the researchers in APSG-J.)

37 Shiroshita A, Matsui H, Yoshida K, Shiraishi A, Tanaka Y, Nakashima K, Aoshima M. Safety of the anterior approach versus the lateral approacgh for chest tube insertion by residents treating spontaneous pneumothorax: a propensity score weihted analysis. Gen Thorac Cardiovasc Surg. 2020 Dec;68(12):1425-1431. doi: 10.1007/s11748-020-01403-5. Epub 2020 Jun 9.

38 Jumpei Taniguchi, Kei Nakashima, Takuto Matsuura, Akira Yoshikawa, Koichi Honma, Yuya Homma, Norihiko Kubota, Michinori Yoshimi, Ayumu Otsuki, Hiroyuki Ito,
Long-term survival of a patient with uterine cancer-induced pulmonary tumor thrombotic microangiopathy following treatment with platinum-based chemotherapy and bevacizumab: A case report, Respiratory Medicine Case Reports 2021;33,101447

39 Kyosuke Seguchi, Kei Nakashima, Toshiki Terao, Gaku Takeshita, Tatsuya Nagai, Yu Tanaka, Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report, Respiratory Medicine Case Reports, 2021;33:101439

40 Nobuhiro Oda, Kei Nakashima, Yuya Homma, Norihiko Kubota, Junpei Taniguchi, Tatsuya Nagai, Michinori Yoshimi, Ayumu Otsuki, Hiroyuki Ito. Simultaneous treatment for Mycobacterium-avium complex lung disease and allergic bronchopulmonary aspergillosis: A case report. Respir Med Case Rep. 2021 Jul 24;34:101488.

41 Taniguchi J, Nakashima K, Ito H, Tanaka Y, Otsuki A, Shiroshita A, Yoshimi M, Kubota N, Aoshima M. Pulmonary Sarcoidosis Presenting with Acute Respiratory Failure: A Report of a Case Diagnosed by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration on Ventilation after Intubation Intern Med. 2020 Sep 15;59(18):2291-2295.

42　Yamada M, Nakashima K, Ito H, Aoshima M. Severe acute respiratory failure due to Sai-rei-to-induced lung injury successfully treated by multi-modal therapy including immunosuppressive therapy, plasma exchange, and intravenous immunoglobulin: A case report. Respir Med Case Rep. 2019 Oct 16;28:100955.

43 Taniguchi J, Nakashima K, Matsui H, Watari T, Otsuki A, Ito H, Otsuka Y. Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study. BMC Infect Dis. 2021 Nov 29;21(1):1200.

44 Nakashima K, Misawa M, Otsuki A, Narita K, Otsuka Y, Matsue K, Aoshima M. Efficacy and Safety of Endobronchial Ultrasonography with a Guide-sheath for Acute Pulmonary Lesions in Patients with Haematological Diseases. Intern Med. 2022;61(5):623-632.

45 Kondo K, Suzuki K, Washio M, Ohfuji S, Adachi S, Kan S, Imai S, Yoshimura K, Miyashita N, Fujisawa N, Maeda A, Fukushima W, Hirota Y; Pneumonia in Elderly People Study Group. Association between coffee and green tea intake and pneumonia among the Japanese elderly: a case-control study. Sci Rep. 2021 Mar 10;11(1):5570. (Kei Nakashima was acknowledged as one of the researchers in Pneumonia in Elderly People Study Group))

46 High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors.
Dhoubhadel BG, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Ishida M, Hamaguchi S, Aoshima M, Yasunami M, Ariyoshi K, Morimoto K; Adult Pneumonia Study Group-Japan (APSG-J).Thorax. 2022 Apr 26:thoraxjnl-2021-217979. (Kei Nakashima was acknowledged as one of the researchers in Pneumonia in Elderly People Study Group))

47Jumpei Taniguchi, Kei Nakashima, Hiroki Matsui, Tatsuya Nagai, Ayumu Otsuki, Hiroyuki Ito, Hiroshi Sugimura The relationship between chest tube position in the thoracic cavity and treatment failure in patients with pleural infection: a retrospective cohort study BMC Pulm Med. 2022 Sep 20;22(1):358.

48 Kei Nakashima, Kanzo Suzuki, Masahiro Aoshima, Mayumi Murabata, Kyoko Kondo, Satoko Ohfuji,, Wakaba Fukushima,, Akiko Maeda, Yoshio Hirota, Pneumonia in Elderly People Study Group Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan Vaccine. 2022 Nov 2;40(46):6589-6598.

49 Nakashima K, Ishida M, Matsui H, Yoshida C, Nagai T, Shiraga M, Nakaoka H, Otsuka Y, Nakagama Y, Kaku N, Nitahara Y, Kido Y, Hirota Y. Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study. Hum Vaccin Immunother. 2022 Nov 11:2140549. doi: 10.1080/21645515.2022.2140549. Epub ahead of print. PMID: 36369871.

50 Takashi Yoshioka, Tomohiro Shinozaki, Ai Hori, Sumiyo Okawa, Kei Nakashima, Takahiro Tabuchi Association between exposure to secondhand aerosol from heated tobacco products and respiratory symptoms among current non-smokers in Japan: a cross-sectional study BMJ Open. 2023 Mar 7;13(3):e065322. doi: 10.1136/bmjopen-2022-065322.

51 Motomura Y, Nakashima K, Harada S, Tochigi K, Fujioka H, Nagai T, Otsuki A, Ito H. Idiopathic Lymphocytic Pleuritis Responding to Corticosteroid Therapy: A Case Report. Intern Med. 2023 May 17. doi: 10.2169/internalmedicine.1240-22. Epub ahead of print. PMID: 37197953.

52 Nagai T, Yoshida K, Otsuki A, So Y, Karumai T, Sugimura H, Tachibana Y, Fukuoka J, Ito H, Nakashima K. Left Main Bronchus Obstruction in a Patient with Small-cell Lung Cancer Successfully Treated with Venovenous Extracorporeal Membrane Oxygenation: A Case Report. Intern Med. 2023 May 31. doi: 10.2169/internalmedicine.1005-22. Epub ahead of print. PMID: 37258171.

53 Taniguchi J, Matsui H, Nagai T, Otsuki A, Ito H, Sugimura H, Nakashima K. Association between intrapleural urokinase monotherapy and treatment failure in patients with pleural infection: a retrospective cohort study. BMC Pulm Med. 2023 Jul 21;23(1):273. doi: 10.1186/s12890-023-02559-5. PMID: 37479981; PMCID: PMC10362621.

54 Nakashima K, Homma Y, Taniguchi J, Kubota N, Otsuki A, Ito H, Otsuka Y, Kondo K, Ohfuji S, Fukushima W, Hirota Y. Immunogenicity and safety of influenza vaccine in patients with lung cancer receiving immune checkpoint inhibitors: A single-center prospective cohort study. J Infect Chemother. 2023 Jul 20:S1341-321X(23)00170-8. doi: 10.1016/j.jiac.2023.07.008. Epub ahead of print. PMID: 37481070.

55 Nagai T, Matsui H, Fujioka H, Homma Y, Otsuki A, Ito H, Ohmura S, Miyamoto T, Shichi D, Tomohisa W, Otsuka Y, Nakashima K. Low- Versus Conventional-Dose Trimethoprim-Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Non-Human Immunodeficiency Virus-Infected Patients: A Multi-Center, Retrospective Observational Cohort Study. Chest. 2023 Aug 11:S0012-3692(23)05269-8. doi: 10.1016/j.chest.2023.08.009. Epub ahead of print. PMID: 37574166.

56 Yamada K, Taniguchi J, Kubota N, Kawai T, Idemitsu R, Inoshima N, Fujioka H, Homma Y, Tochigi K, Yamamoto S, Nagai T, Otsuki A, Ito H, Nakashima K. Empyema and bacteremia caused by Parvimonas micra: A case report. Respir Med Case Rep. 2023 Jul 4;45:101892. doi: 10.1016/j.rmcr.2023.101892. PMID: 37577121; PMCID: PMC10413192.

57. Wakabayashi T, Hamaguchi S, Morimoto K; Adult Pneumonia Study Group – Japan. Clinically defined aspiration pneumonia is an independent risk factor associated with long-term hospital stay: a prospective cohort study. BMC Pulm Med. 2023 Sep 18;23(1):351. doi: 10.1186/s12890-023-02641-y. PMID: 37718411; PMCID: PMC10506309. (Kei Nakashima was acknowledged as one of the researchers in APSG-J.)

58. Otsuki A, Inoshima N, Tochigi K, Ito H, Nakashima K. Efficacy and safety of 40 mg osimertinib administered every other day for non-small cell lung cancer harboring an epidermal growth factor receptor mutation: A single-center retrospective cohort study. Thorac Cancer. 2024 Jan 27. doi: 10.1111/1759-7714.15226. Epub ahead of print. PMID: 38279684.

59. Maeda H, Saito N, Igarashi A, Ishida M, Terada M, Masuda S, Osawa R, Hosokawa N, Nakashima K, Kamura H, Imura H, Inoue H, Matsuzaka S, Sugimoto Y, Kuwamitsu O, Motohashi I, Morikawa T, Oda R, Hoshina Y, Matono T, Teshigahara O, Sando E, Asami S, Kudo S, Akizuki N, Muto Y, Hayakawa T, Kishaba T, Ohara Y, Kubo Y, Suzuki M, Morimoto K. Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS). Expert Rev Vaccines. 2024 Jan-Dec;23(1):213-225. doi: 10.1080/14760584.2024.2310807. Epub 2024 Feb 8. PMID: 38288980.

60 Yamamoto S, Matsui H, Fujioka H, Homma Y, Kubota N, Otsuki A, Ito H, Sagara H, Nakashima K. Predictors of improvement of radial-endobronchial ultrasonography findings from “adjacent to” to “within” in endobronchial ultrasonography using a guide sheath: a retrospective cohort study. J Thorac Dis 2024;16(1):264-272. doi: 10.21037/jtd-23-1234

61 Ohmura SI, Matsui H, Miyamoto T, Shichi D, Masui T, Ichijo K, Homma Y, Fujioka H, Nagai T, Nakashima K. Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics. Respir Investig. 2024 May;62(3):377-383. doi: 10.1016/j.resinv.2024.02.015. Epub 2024 Mar 6. PMID: 38452442.

62 Nakashima K, Fukushima W. Strategies for pneumococcal vaccination in older adults in the coming era. Hum Vaccin Immunother. 2024 Dec 31;20(1):2328963. doi: 10.1080/21645515.2024.2328963. Epub 2024 Mar 22. PMID: 38517265; PMCID: PMC10962601.